近日，首都医科大学附属北京中医医院刘红旭、邢文龙团队联合8家医疗机构完成的安宫降压丸临床研 究结果，发表于《Journal of Traditional Chinese Medicine》（JTCM）杂志，该研究以国际规范的试验设 计，为肝阳上亢型二级高血压治疗提供了新的循证依据，其成果背后的临床价值与应用前景值得深入解 读。 一、血压控制效果：降幅显著，达标率具备临床实用价值 注：药物使用需在专业医师指导下，根据辨证结果合理用药。 同时，其与 CCB+ARB、CCB+β受体阻滞剂两种主流联合降压方案联用均展现稳定协同效果，这一结果 具有重要的临床实践价值。目前，这两类联合方案是临床上治疗二级高血压的常用选择，安宫降压丸与 它们的良好协同性，意味着无需调整现有主流治疗框架，即可纳入该药进行协同治疗，降低了临床应用 的门槛，更易被医师和患者接受。 三、安全性与学术意义：为中医药现代化与中西医协同提供范本 试验期间未发生相关不良事件，充分证明了安宫降压丸在联合用药场景下的安全性，这对于需要长期服 药的高血压患者而言至关重要，也为其长期临床应用奠定了基础。 作为北京同仁堂传承百年的经典中成药，安宫降压丸由郁金、黄连 ...

新华社北京12月10日电 日前，第二届中国呼吸健康大会在广州举行。本次大会以"中西医协同·产学 研创新：共筑呼吸健康新格局"为主题，由中国工程院院士钟南山、张伯礼共同担任大会主席，汇聚了 包括中国科学院院士徐涛在内的近2000名呼吸病学、中医药学等领域的产学研代表，围绕呼吸系统疾 病"筛、防、诊、治、康"全周期管理展开深度对话和成果展示。 多位院士表示，医学创新关键在于要能为临床实践带来切实改变，要推动科研成果真正惠及百姓， 服务人民健康。 开幕式上，中国工程院院士钟南山着重强调医学融合与科技创新的核心价值。他指出，创新不仅局 限于颠覆性理论或产品，关键在于能否为临床实践带来切实改变。特别是在重大疾病防治方面，学科优 势互补与科研成果高效转化是医学进步的关键。呼吸健康事关民生与公共卫生安全，要面向人民健康， 研发推广适合中国国情的简便、价廉、有效的技术与方案。 "党的二十届四中全会相关部署为卫生健康事业指明了方向，强调呼吸健康是健康中国战略的重要 组成部分。"中国工程院院士张伯礼围绕"中西医协同"这一核心主题，指出"中西医协同"并非简单叠 加，而是优势互补、深度融合，需共同探索临床诊疗的新思路、新方法，让科研 ...

Core Viewpoint - The Guangdong provincial government emphasizes the importance of improving people's livelihoods while pursuing high-quality economic development, aligning with the "Hundred Million Thousand Project" to enhance public welfare [1] Group 1: Government Initiatives - The Guangdong provincial government report highlights the commitment to safeguard and improve living standards as part of economic development [1] - The Dongguan Municipal Party Committee's meeting focuses on the implementation of the "Hundred Million Thousand Project" to promote high-quality development and enhance public welfare [1] Group 2: Healthcare Innovations - Liaobu Hospital integrates party building into chronic disease management, creating a unique mechanism that promotes proactive health management [2] - The hospital has established the first Traditional Chinese Medicine weight management center in Dongguan, utilizing innovative techniques to achieve significant weight loss results for patients [2] Group 3: Diabetes Management - The establishment of Dongguan's first diabetes reversal center employs a "2+N system" for effective blood sugar control, leading to high medication cessation rates among patients [3] - The hospital has developed a three-tier health network to extend quality medical resources to the community, training over 1,500 grassroots healthcare workers [3] Group 4: Comprehensive Health Management - Liaobu Hospital's innovative management system enhances patient compliance and integrates various treatment methods, showcasing the advantages of combining traditional and modern medicine [4] - The hospital's efforts have resulted in significant health improvements for the community, establishing a strong reputation and attracting interest from over 50 medical institutions [4]

Group 1: Healthcare Initiatives - A free health consultation and diagnosis event was held in Qinhuangdao, Hebei Province, providing services from orthopedic, traditional Chinese medicine, internal medicine, and geriatric specialists [2] - The 2025 China International Service Trade Fair in Beijing focused on digital, intelligent, and green trends in service trade, showcasing innovations in fields like artificial intelligence and healthcare [4] Group 2: Health System Development - During the 14th Five-Year Plan period, China established the world's largest disease prevention and control system, aiming for a life expectancy of 79 years by 2024 and improving health literacy to 31.9% [8] - The National Health Commission reported improvements in healthcare service quality and efficiency, with 87% of secondary and higher public hospitals offering appointment services and a significant increase in internet hospital visits [10] Group 3: Elderly and Child Health Services - Policies were introduced to enhance health services for the elderly, with 84.6% of secondary hospitals having geriatric departments and a focus on multi-disease treatment models [11] - Child healthcare services were also improved, with a 49.3% increase in pediatric practitioners and a rise in pediatric bed availability [12] Group 4: Traditional Chinese Medicine - The number of traditional Chinese medicine consultations increased by 60% since the end of the 13th Five-Year Plan, with a high coverage of TCM facilities in county-level medical institutions [14] - Efforts to enhance TCM services included establishing collaborative mechanisms between TCM and Western medicine, improving treatment outcomes for various diseases [15] Group 5: Disease Control and Prevention - A modernized disease control system was established, enhancing monitoring and emergency response capabilities, with significant improvements in infectious disease management [16][17] - The introduction of new vaccination programs, including HPV vaccines for girls, reflects ongoing efforts to improve public health [18]

Core Viewpoint - The integration of traditional Chinese medicine (TCM) and Western medicine is being prioritized at the national level in China, with systematic measures being implemented to modernize and internationalize TCM [1][3]. Group 1: Policy and Strategic Development - The "14th Five-Year Plan for TCM Development" emphasizes the promotion of evidence-based research in TCM [1]. - Continuous support for the collaborative practice of TCM and Western medicine is evident through various policies [1]. - The national strategy aims to enhance the clinical efficacy of TCM in managing chronic diseases and infectious diseases [1]. Group 2: Clinical Practice and Research - Current collaboration between TCM and Western medicine often remains superficial, lacking deep integration of theoretical frameworks [1]. - There is a need for standardized efficacy evaluation criteria to facilitate the promotion of collaborative treatment protocols [1]. - Research indicates that TCM has shown positive results in treating conditions like acute cough and sore throat, providing strong evidence for its efficacy as an alternative to antibiotics [5][6]. Group 3: International Recognition and Challenges - The inclusion of TCM in clinical guidelines of developed countries is crucial for its international recognition [4]. - Key challenges for TCM's acceptance in the UK include the lack of GMP certification, the need for balancing standardization with personalization in treatment, and overcoming biases against TCM [5][6]. - Training and evidence-based communication are essential for the effective implementation of clinical guidelines that include TCM [6]. Group 4: Methodological Innovations - The development of a robust evidence system to support TCM's clinical value is critical, focusing on optimizing research methodologies [7][8]. - There is a call for high-quality practice guidelines and the exploration of personalized treatment methods that align with TCM principles [9][10]. - The integration of modern technologies like genomics and systems biology can enhance the understanding of TCM's biological foundations [9][10]. Group 5: Global Integration and Future Directions - The exploration of TCM and Western medicine integration offers valuable insights for global traditional and modern medicine fusion [10][11]. - The Chinese experience in TCM and Western medicine integration serves as a reference for global healthcare systems [11][12]. - Future efforts should focus on scientific support and patient-centered approaches to deepen the integration of TCM and Western medicine [12][15].